CONCENTRA GROUP HOLDINGS PARENT, INC. vs FRESENIUS MEDICAL CARE AG, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CON and FMS diverge most: on p/b, CON reads 9.80 and FMS reads 0.79; on revenue growth, CON reads +14.2% and FMS reads +1.5%. The rest of the comparable metrics sit closer together. What FMS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CON | FMS |
|---|---|---|
| Price | $37.18 | $21.05 |
| Market cap | $4.8B | $12.3B |
| Sector | Medical Care | Medical Care |
| Stage | Growth | Mature |
| Implied growth (priced in) | -1.4% | — |
| P/E | 24.0 | 11.5 |
| P/B | 9.80 | 0.79 |
| P/S | 2.08 | 0.58 |
| EV/EBITDA | 13.6 | 5.2 |
| Revenue growth | +14.2% | +1.5% |
| Operating margin | 19.0% | 11.7% |
| Net margin | 8.7% | 6.1% |
| Return on equity | 41.0% | 8.3% |
| Return on assets | 6.6% | 3.8% |
| Return on invested capital | 13.7% | 6.7% |
| FCF yield | 5.6% | 23.7% |
| Dividend yield | 0.7% | 1.9% |
| Debt / equity | 3.25 | 0.51 |
| Current ratio | 1.38 | 1.26 |
| Altman Z (solvency) | 2.19 | 1.72 |
| Piotroski F (quality) | 8 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.